LifeScience Clinical & Diagnostic
Everest Medicines (HKEX 1952.HK)'s partner Venatorx Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has accepted the company's N...
August 16, 2023 | News
"We are delighted to announce the IND approval for our flagship program, CUSP06, which has demonstrated excellent anti-tumor efficacy across diverse in&nbs...
August 16, 2023 | News
Non-profit drug developer TB Alliance has granted Remington Pharmaceutical Industries (Pvt.) Ltd. a non-royalty bearing license to market the anti-tubercul...
August 15, 2023 | News
Combined company will operate as Sunbird Bio and focus on advancing clinical-stage platforms with demonstrated potential to enhance patient care in A...
August 14, 2023 | News
The study is a prospective, self-controlled, multicenter Phase Ⅲ trial aimed at investigating the additional detection rate and safety of Hexvix®&nbs...
August 14, 2023 | News
As a globally trusted innovator in medical devices and solutions, Mindray brings cutting-edge technology and medical expertise to the collaboration. Throug...
August 09, 2023 | News
In the initial phase of the AF360 campaign, Pfizer, via its distributor, has provided registered medical portable ECG screening devices to Sunway Multicare...
August 08, 2023 | News
Camtech's Ideal Health DNA genetic test offers a comprehensive kit that analyses 56 unique traits related to skin, fitness, nutrition, and ageing. The type...
August 03, 2023 | News
The newly-installed service functions like Google Maps, but has been specifically developed to work indoors with a 10 to 20 times higher accuracy than GPS ...
August 03, 2023 | News
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced U.S. Food and Drug Administration (FDA) 510(k)...
August 02, 2023 | News
Lupin Pharmaceuticals Inc. (Lupin) is voluntarily recalling two (2) lots of Tydemy (Drospirenone, Ethinyl Estradiol and Levomefolate Calcium Tablets 3mg/0....
July 31, 2023 | News
AI Medical Service Inc. (hereinafter AIM), a medical start-up specializing in the development of diagnostic endoscopic AI, has signed a joint research...
July 28, 2023 | News
The Company proposes to adopt a randomized, double-blind, Shingrix® parallel controlled phase I clinical trial in 180 healthy adult subjects aged 40 an...
July 27, 2023 | News
''We can gain vital insights into patient prognosis and make informed decisions regarding the most effective treatment strategies through ctDNA CNA...
July 27, 2023 | News
Most Read
Bio Jobs
News